Ribonucleic Acid News and Research

RSS
mRNA COVID-19 vaccines are highly effective among front liners, CDC study shows

mRNA COVID-19 vaccines are highly effective among front liners, CDC study shows

Study finds rapid increase in IgG and IgA antibody levels following COVID-19 mRNA vaccination

Study finds rapid increase in IgG and IgA antibody levels following COVID-19 mRNA vaccination

Could an mRNA vaccine second dose reduce cellular immunity in previously infected individuals?

Could an mRNA vaccine second dose reduce cellular immunity in previously infected individuals?

Could dry swabs provide cheaper, safer and faster material for SARS-CoV-2 testing?

Could dry swabs provide cheaper, safer and faster material for SARS-CoV-2 testing?

Modeling study predicts SARS-CoV-2 variants with high receptor binding affinity

Modeling study predicts SARS-CoV-2 variants with high receptor binding affinity

Clofazimine inhibits coronaviruses including SARS-CoV-2, study finds

Clofazimine inhibits coronaviruses including SARS-CoV-2, study finds

SARS-CoV-2 spike stimulates hyperinflammation via Toll-like receptor 2

SARS-CoV-2 spike stimulates hyperinflammation via Toll-like receptor 2

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

An overview of the BNT162b2 COVID-19 vaccine by Pfizer-BioNTech

An overview of the BNT162b2 COVID-19 vaccine by Pfizer-BioNTech

TraCK study says schoolchildren unlikely to transmit SARS-CoV-2

TraCK study says schoolchildren unlikely to transmit SARS-CoV-2

Danish study on the efficacy of Pfizer/BioNTech SARS-CoV-2 vaccine after first and second dose

Danish study on the efficacy of Pfizer/BioNTech SARS-CoV-2 vaccine after first and second dose

mRNA COVID-19 vaccines show high efficacy in pregnancy and lactation

mRNA COVID-19 vaccines show high efficacy in pregnancy and lactation

SARS-CoV-2 variants rapidly arise in non-human hosts, potential risk for human reinfection

SARS-CoV-2 variants rapidly arise in non-human hosts, potential risk for human reinfection

Optimized SARS-CoV-2 vaccine candidate could be less reactogenic, say researchers

Optimized SARS-CoV-2 vaccine candidate could be less reactogenic, say researchers

Proteomics shows SARS-CoV-2 NSP7 and NSP8 forms stable dimeric unit

Proteomics shows SARS-CoV-2 NSP7 and NSP8 forms stable dimeric unit

Two doses of Pfizer-BioNTech SARS-CoV-2 vaccine induce humoral protection against U.K. and S.A. variants

Two doses of Pfizer-BioNTech SARS-CoV-2 vaccine induce humoral protection against U.K. and S.A. variants

Apoptosis is an important mediator of pathogenesis in animal coronavirus infection

Apoptosis is an important mediator of pathogenesis in animal coronavirus infection

Novel bioinformatics tool could help improve COVID-19 diagnosis

Novel bioinformatics tool could help improve COVID-19 diagnosis

A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo

A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo

Novel host-viral-microbiome interactions during COVID-19 may determine outcome

Novel host-viral-microbiome interactions during COVID-19 may determine outcome